Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06255704
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-13
First Post:
2024-02-05
Brief Title:
A Single-arm Single-center Open-label Phase II Study of Zanubrutinib Combined With R-CHOPR-DHAP in Newly Diagnosed Mantle CellLymphoma Patients
Sponsor:
Shanxi Province Cancer Hospital
Organization:
Shanxi Province Cancer Hospital
Organization Data
Organization:
Shanxi Province Cancer Hospital
Class:
OTHER
Study ID:
MCL BTKi immunochemotherapy
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanxi Province Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None